Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

15561 - 15570 of 44979 results found

Repurposing of H1-receptor antagonists (levo)cetirizine, (des)loratadine, and fexofenadine as a case study for systematic analysis of trials on clinicaltrials.gov using semi-automated processes with custom-coded software

Date
Monday, October 23, 2023 - 4:00 AM
Description
To gain a comprehensive overview of the landscape of clinical trials for the H(1)-receptor antagonists (H(1)R antagonists) cetirizine, levocetirizine, loratadine, desloratadine, and fexofenadine and their potential use cases in drug repurposing (the

Tetanus: an immunopreventable disease

Date
Monday, October 23, 2023 - 4:00 AM
Description
Tetanus is an infectious disease caused by a ubiquitous bacterium Clostridium tetani, that synthesizes and releasesa potent neurotoxin under anaerobic conditions, which is responsible for the clinical manifestations. As it is found in soil

Bacterial coinfection in young febrile infants with SARS-CoV-2 infection

Date
Monday, October 23, 2023 - 4:00 AM
Description
We aimed to assess the prevalence of serious bacterial infections (SBIs) in febrile infants 90 days of age with SARS-CoV-2 infection versus SARS-CoV-2-negative febrile infants. A retrospective cohort study was conducted in a tertiary pediatric